Neuronal experiments show that SYNJ2BP overexpression increases MERC, alters neuronal mitochondrial distribution, and leads to significant reduction and damage of axonal mitochondria, which is considered a pathology of AD [51, 53]. Here, SYNJ2BP is linked to Alzheimer disease.